Phase 3 post-hoc analysis indicates less fentanyl and overall illicit opioid use for weekly/monthly buprenorphine depots versus daily standard treatment in a difficult to treat patient population LUND ...
- Individualized treatment of opioid dependence with weekly and monthly Buvidal ® was well-tolerated and effective, with a high (73.6%) patient retention across the 48-week study - 83.4% of ...
11d
‘My independence was handed back to me’: Long-acting injection helping those with opioid addictions
Methadone is a treatment used for those with an opioid addiction, but requires at least one weekly supervised visit to a clinic. Users of Buvidal, a long-acting treatment, receive a monthly injection, ...
Camurus, a Swedish research-based pharmaceutical company, announced that the European Commission (EC) has approved weekly and monthly Buvidal (prolonged release buprenorphine) for the treatment of ...
LUND, Sweden , May 10, 2021 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) announces today the publication in JAMA Network Open of results from a 24-week, randomized, controlled trial (DEBUT) comparing ...
A drug used in a pilot scheme to help prisoners affected by heroin addiction is to be rolled out across Scotland. Buvidal acts as a replacement treatment for methadone, with patients receiving an ...
Camurus, a Swedish, science-led biopharmaceutical company, announced topline results from the 24-week, randomized, controlled, open-label, DEBUT study of weekly and monthly Buvidal (prolonged-release ...
The EU’s Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of a new dose of Camurus’ prolonged-release injection opioid dependence treatment. Buvidal, which contains ...
LUND, Sweden, Nov. 26, 2019 /PRNewswire/ -- Camurus announced today topline results from the 24-week, randomized, controlled, open-label, DEBUT study of weekly and monthly Buvidal® (prolonged-release ...
LUND, Sweden, Nov. 22, 2018 /PRNewswire/ -- Camurus announced today that the European Commission (EC) has approved weekly and monthly Buvidal® (prolonged release buprenorphine) for the treatment of ...
A recovering heroin addict says a new treatment being trialled in the West Midlands is like "being given the keys to a new life". Buvidal is a monthly injection that replaces daily treatments like ...
People currently on a methadone programme have to take the drug daily A drug used in a pilot scheme to help prisoners affected by heroin addiction is to be rolled out across Scotland. Buvidal acts as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results